Ignite Creation Date:
2024-05-06 @ 12:53 PM
Last Modification Date:
2024-10-26 @ 1:05 PM
Study NCT ID:
NCT03876587
Status:
UNKNOWN
Last Update Posted:
2019-03-15
First Post:
2019-03-11
Brief Title:
Pyrotinib Combined With Docetaxel in the First-line Treatment of HER2-positive MBC
Sponsor:
Zhejiang Cancer Hospital
Organization:
Zhejiang Cancer Hospital
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-03
Start Date Type:
ESTIMATED
Primary Completion Date:
2019-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2020-12
Completion Date Type:
ESTIMATED
First Submit Date:
2019-03-11
First Submit QC Date:
March 12 2019
Study First Post Date:
2019-03-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-03-12
Last Update Post Date:
2019-03-15
Last Update Post Date Type:
ACTUAL